Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1552 of 5804
-
New brain stimulation device shows promise for Parkinson's patients
Disease control CompletedThe purpose of this study is to demonstrate the safety and effectiveness of the PINS Deep Brain Stimulation (DBS) system, including the G107R/G107 IPG, L305/L306 directional leads, E204 extensions and related system components.
Phase: NA • Sponsor: Beijing Pins Medical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could the 'Love Hormone' help teens lose weight?
Disease control Recruiting nowThis is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin in youths with obesity, ages 10-18 years old. Subjects will be randomized to receive intranasal oxytocin or placebo (1 spray per nostril, 4 times per day) for 12 weeks. Study visits…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New drug shows promise for tough Crohn's cases
Disease control CompletedThe purpose of this study is to assess the safety and efficacy of tulisokibart (MK-7240) in participants with moderately to severely active Crohn's Disease. After the completion of the 12-week Induction Period, eligible participants have the option to enter an Open-label Extensi…
Phase: PHASE2 • Sponsor: Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Egg freezing may shield fertility from repeat ovarian cyst surgeries
Disease control CompletedBenign ovarian cysts are frequent during women's life. They are diagnosed with pelvic pain or fortuitously during an ultra-sonographic exam. In case of persistence,a surgery will be necessary to identify the nature of the cyst and assess its benignity. In some case, cysts are rec…
Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug combo shows promise for tough cancers
Disease control CompletedThis is a phase II, single arm, open-label study of two parallel cohorts (advanced stomach and gastroesophageal junction cancer and hepatocellular carcinoma), evaluating the effects of telatinib in combination with Keytruda on progression-free survival.
Phase: PHASE2 • Sponsor: Andrew Hendifar, MD • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New lupus drug tested for Long-Term safety in large trial
Disease control ENROLLING_BY_INVITATIONThe purpose of this study is to evaluate long-term safety and tolerability of dapirolizumab pegol treatment.
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New catheter device aims to repair leaky mitral valves in high-risk patients
Disease control Recruiting nowSafety and performance evaluation of the CardioMech Mitral Valve Repair System (MVRS) in patients with degenerative mitral valve regurgitation.
Phase: NA • Sponsor: CardioMech AS • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New asthma drug shows promise in early trial
Disease control Recruiting nowThis is a randomized, placebo-controlled and double-blind study to evaluate the efficacy and safety of FB825 in adult patients with moderate-to-severe allergic asthma.
Phase: PHASE2 • Sponsor: Oneness Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug shows promise for Hard-to-Treat cancers
Disease control CompletedThe objective of this study is to evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of MRG004A in patients with Tissue Factor positive advanced or metastatic solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Lepu Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug cocktail aims to shrink Hard-to-Treat bladder tumors
Disease control Recruiting nowThis phase I/Ib trial seeks to find out the best dose, possible benefits and/or side effects of cabozantinib in combination with enfortumab vedotin in treating urothelial cancer that has spread to nearby tissues and lymph nodes (locally advanced) or other parts of the body (metas…
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a treadmill plus brain games help stroke patients walk again?
Symptom relief OngoingIn this research study, the investigators aim to test the usability and efficacy of the GaitBetter system for gait rehabilitation after stroke.
Phase: NA • Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New drug combo shows promise for rare salivary gland cancer
Disease control OngoingThis phase II trial studies the effect of pemetrexed and pembrolizumab in treating patients with salivary gland cancer that has come back (recurrent) and/or has spread to other places in the body (metastatic). Chemotherapy drugs, such as pemetrexed, work in different ways to stop…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
AI reads brain scans to spot Parkinson's lookalikes
Diagnosis OngoingThe purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagn…
Sponsor: University of Florida • Aim: Diagnosis
Last updated Jun 28, 2026 00:00 UTC
-
New catheter aims to tame irregular heartbeat
Disease control Recruiting nowA prospective, single-arm, single-center study to evaluate the safety, performance, and effectiveness of the SpherePVI™ Catheter for treating paroxysmal AF.
Phase: NA • Sponsor: Medtronic Cardiac Ablation Solutions • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for bone sarcoma: regorafenib maintenance trial launches
Disease control Recruiting nowThis is a multicenter phase II study concerning patients with high-grade bone sarcoma (HGBS) without complete remission after standard treatment at diagnosis or at relapse. Patients will be treated with regorafenib + best supportive care (BSC) for a maximum of 12 months as maint…
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for chinese patients with spinal arthritis: phase 3 drug trial shows promise
Disease control CompletedThe purpose of this study was to evaluate the efficacy, safety, and tolerability of secukinumab in Chinese patients with active non-radiographic axial spondyloarthritis (nr-axSpA).
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Teen kidney transplant patients may get a better drug option
Disease control Recruiting nowThe purpose of this study is to evaluate the benefits and risks of conversion of existing adolescent kidney allograft recipients aged 12 to less than 18 years of age to a belatacept-based immunosuppressive regimen as compared to continuation of a calcineurin inhibitor-based regim…
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug cocktail aims to stall pancreatic cancer
Disease control OngoingThis phase II trial studies the effects of lenvatinib and pembrolizumab maintenance therapy in treating patients with pancreatic cancer that has spread to other places in the body (advanced) and cannot be removed by surgery (unresectable). Lenvatinib may stop the growth of tumor …
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Brain zaps for BPD depression: new hope or hype?
Symptom relief OngoingThis study evaluates the antidepressant effects of an accelerated schedule of theta-burst stimulation, termed accelerated intermittent theta-burst stimulation (aiTBS), in individuals with borderline personality disorder (BPD) or trait and comorbid mood depressive disorder (MDD) o…
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New glasses could slow Kids' nearsightedness over 3 years
Disease control OngoingThis is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.
Phase: NA • Sponsor: SightGlass Vision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC